MultiGeneAngio (Compugen)

N/A

Report date: 2022/11/20 14:17:09

Base Information

Drug NameMultiGeneAngio (Compugen)
Drug Alias Nameautologous VEGF-and angiopoietin-1-expressing endothelial and smooth muscle cell therapyMultiGeneAngioMGA
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionStem cell replacementsVEGF gene stimulantsAngiopoietin-1 modulators
TargetsVascular endothelial growth factorAngiopoietin-1
Therapy Area/IndicationsPeripheral Arterial Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCompugen Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCompugen Ltd
Inactive CompaniesN/A
Active IndicationsPeripheral Arterial Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A